2.04
price down icon3.32%   -0.07
 
loading
Schlusskurs vom Vortag:
$2.11
Offen:
$2.1
24-Stunden-Volumen:
11,197
Relative Volume:
0.04
Marktkapitalisierung:
$101.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-123.57M
KGV:
-0.6711
EPS:
-3.04
Netto-Cashflow:
$-97.53M
1W Leistung:
-5.12%
1M Leistung:
+0.99%
6M Leistung:
+3.55%
1J Leistung:
+15.25%
1-Tages-Spanne:
Value
$2.03
$2.10
1-Wochen-Bereich:
Value
$2.03
$2.17
52-Wochen-Spanne:
Value
$1.34
$2.17

Hillevax Inc Stock (HLVX) Company Profile

Name
Firmenname
Hillevax Inc
Name
Telefon
(617) 213-5054
Name
Adresse
321 HARRISON AVE, SUITE 500, BOSTON
Name
Mitarbeiter
14
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-28
Name
Neueste SEC-Einreichungen
Name
HLVX's Discussions on Twitter

Vergleichen Sie HLVX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
HLVX
Hillevax Inc
2.03 104.71M 0 -123.57M -97.53M -3.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.00 120.48B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
549.29 59.88B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
394.76 44.31B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
674.52 36.65B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.64 32.46B 3.81B -644.79M -669.77M -6.24

Hillevax Inc Stock (HLVX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-09 Herabstufung H.C. Wainwright Buy → Neutral
2024-07-09 Herabstufung Leerink Partners Outperform → Market Perform
2024-07-09 Herabstufung Stifel Buy → Hold
2024-07-08 Herabstufung Guggenheim Buy → Neutral
2024-07-08 Herabstufung JP Morgan Overweight → Neutral
2023-12-13 Eingeleitet H.C. Wainwright Buy
Alle ansehen

Hillevax Inc Aktie (HLVX) Neueste Nachrichten

pulisher
06:15 AM

What makes HilleVax Inc. stock price move sharplyValue Holding Return Summary With Outlook - Newser

06:15 AM
pulisher
02:14 AM

Will HilleVax Inc. stock recover after recent dropFree High Yield Stock Screening Results - Newser

02:14 AM
pulisher
Jul 31, 2025

How HBANM stock compares to its top competitorsIs HilleVax Inc. stock undervalued or overvalued nowFree High Accuracy Alerts for ROI Traders - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

What are analysts’ price targets for HilleVax Inc. in the next 12 monthsReal Time Ideas With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about HilleVax Inc.Free Stock Forecasts That Work - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

Applying big data sentiment scoring on HilleVax Inc.Weekly Return Pick Forecast Reports Show Trend - metal.it

Jul 31, 2025
pulisher
Jul 31, 2025

Top Risks to Consider Before Buying HilleVax Inc. StockBuy Entry Confirmation Based on Technical Analysis - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Has HilleVax Inc. found a price floorWeekly Breakout Forecast with Entry Zones - Newser

Jul 31, 2025
pulisher
Jul 31, 2025

Is HilleVax Inc. a Top Dividend Stock to Watch in 2025Sector Based Breakout Stock Forecast Issued - metal.it

Jul 31, 2025
pulisher
Jul 30, 2025

Market reaction to HilleVax Inc.’s recent newsSecure Entry Point Finder with Analysis - Newser

Jul 30, 2025
pulisher
Jul 29, 2025

Short Interest Drops in HilleVax Inc. After RallyConsistent Income Focused Trade List Analyzed - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Can volume confirm reversal in HilleVax Inc.Price Action Trading with Volume Confirmation - Newser

Jul 29, 2025
pulisher
Jul 28, 2025

How does HilleVax Inc. generate profit in a changing economyAdvanced Screener Target Finder With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Analysts Apply Wyckoff Model to HilleVax Inc. StockReal Time Trade Opportunity Alerts Monitor Market Surges - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

What catalysts could drive HilleVax Inc. stock higher in 2025Exceptional stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How HBANM stock compares to its top competitorsIs HilleVax Inc. stock undervalued or overvalued now Real-Time Signal Tracking with Entry Level - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

How many analysts rate HilleVax Inc. as a “Buy”Discover undervalued opportunities early - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is HilleVax Inc. company’s growth strategyBuild a portfolio that outperforms the market - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

New Product Launches: Will They Boost HilleVax Inc. Stock in 2025Secure Your Capital Strategy - metal.it

Jul 27, 2025
pulisher
Jul 27, 2025

HilleVax Inc. Stock Performance After Earnings: Historical InsightsWatchlist Winner Update - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why HilleVax Inc. stock attracts strong analyst attentionFree Smart Money Stock Analysis - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

How HilleVax Inc. stock performs during market volatilityGrowth Stock Monitor - Newser

Jul 26, 2025
pulisher
Jul 24, 2025

Is HilleVax Inc. a good long term investmentConsistently outstanding ROI - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about HilleVax Inc. stockConsistently exceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

What drives HilleVax Inc. stock priceConsistently high yield - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives FPAY stock priceAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

HilleVax Inc. Stock Analysis and ForecastHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025

Finanzdaten der Hillevax Inc-Aktie (HLVX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Hillevax Inc-Aktie (HLVX) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
HERSHBERG ROBERT
See Remarks
Feb 11 '25
Sale
1.76
11,901
21,003
1,101,498
Maltbie Shane
Chief Financial Officer
Feb 11 '25
Sale
1.76
4,345
7,659
79,887
Maltbie Shane
Chief Financial Officer
Feb 04 '25
Sale
1.89
3,946
7,458
84,232
$74.58
price down icon 0.32%
$36.82
price down icon 0.09%
$106.93
price down icon 0.15%
$26.25
price down icon 0.64%
$106.19
price down icon 1.35%
biotechnology ONC
$295.74
price down icon 1.74%
Kapitalisierung:     |  Volumen (24h):